Navigation Links
Hunter Shkolnik of Rheingold Valet Moves to Napoli Bern Ripka, LLP
Date:7/12/2011

NEW YORK, July 12, 2011 /PRNewswire/ -- After more than fifteen (15) years as a Senior Partner in the New York personal injury firm Rheingold, Valet, Rheingold, Shkolnik & McCartney, LLP, Hunter Shkolnik has joined Napoli Bern Ripka, LLP ("Napoli Bern") as a Senior Partner of the firm, which will henceforth be known as Napoli Bern Ripka Shkolnik, LLP. Paul Napoli said: "Mr. Shkolnik led the complex and mass tort litigation team at Rheingold, Valet and he has long been active nationally as a leader in Pharmaceutical and Mass Tort litigations. We expect that he will continue to do so in the future".

Mr. Shkolnik has concentrated his areas of practice to the trial of significant personal injury cases primarily in the area of drug, medical device, automobile, heavy truck and aviation related product liability and medical malpractice actions. He serves as a chairman, leader or court appointed representative on Plaintiffs' Steering Committees in various consumer class actions and drug and medical device mass tort litigations including: In re: Toyota Sudden Acceleration Litigation 10:2151: Member, Liaison Counsel Committee For Personal Injury and Wrongful Death Claimants; In re: Oral Sodium Phosphate Solution- Based Products Liability Litigation 09:2066 Co-Lead Counsel; In re: Medtronic Sprint Fidelis Lead Litigation Member, Plaintiffs' Steering Committee; In re: Kaba Simplex Locks Marketing and Sales Practices Litigation; In re: POM Wonderful LLC Marketing and Sales Practices Litigation; In re: Medtronic Implantable Cardiac Defibrillators Litigation 05:1726 Member, Plaintiffs' Steering Committee; In re: Guidant Corp Implantable Defibrillators Products Liability Litigation 05:1708, Plaintiffs' Steering Committee; In re: Nuvaring Products Liability Litigation; New Jersey Levaquin Mass Tort Litigation-Discovery Co-Chair; New Jersey Nuvaring Litigation-Liaison Counsel; Co-Liaison Counsel New Jersey Metaclopromide Mass Tort Litigation. Hunter was a member of the Plaintiff's Steering Committee and a lead counsel in the N.Y. Diet Drug/Phen-Fen litigation; a member of the Plaintiff's Steering Committee and a lead counsel in the N.Y. Sulzer Inter-Op Hip and Knee Implant litigation.

"Shkolnik's diverse experience, combined with that of Napoli Bern Ripka's other Senior Partners and Associate Attorneys will make the firm an even more powerful voice in the legal community," said Napoli Senior Partner Marc Jay Bern. Bern has been practicing since 1975 and has tried cases and lectured throughout the country. He was appointed to the Trasylol Plaintiffs' Steering Committee ("PSC") Executive Committee by the Hon. Donald Middlebrooks of the United States District Court for the Southern District of Florida, sitting on In re: Trasylol Products Liability Litigation (MDL-1928); Mr. Bern is also a member of the discovery committee for In re: MTBE (Methyl Tertiary Butyl Ether) Products Liability Litigation (MDL-1358) pending in the United States District Court for the Southern District of New York before Judge Shira Scheindlin. In addition, Mr. Bern has been appointed to the New Jersey Plaintiffs' Steering Committee for the Levaquin Products Liability Litigation. Senior Partner Paul Napoli has been in practice since 1992 and has extensive experience trying various types of tort cases. He has been named co-liaison counsel for the State of New York Diet Drug (Fen-Phen) litigation and Rezulin litigation. Mr. Napoli was also appointed by the Court to lead the U.S. District Court litigation seeking payment for the Ground Zero workers who suffered respiratory injuries working in the clean up and debris removal efforts at the WTC site following the September 11th attacks. In that capacity, Mr. Napoli recently negotiated the historic $812,500,000.00 settlement on behalf of the Ground Zero workers. The firm represents injured individuals and municipal entities throughout the United States in claims arising from defective products, pharmaceutical mass torts, environmental disasters, professional liability (including medical, dental and podiatric malpractice), complex liability cases and other tragedies involving loss of life or health as a result of the negligence of others. Over the years, Napoli Bern has recovered more than two billion dollars for its clients.

The newly formed firm has its primary offices in the iconic Empire State Building in New York, New York, with offices in Long Island, New Jersey, Miami, Los Angeles and Philadelphia.

Press Release Contact Information:
Hunter Shkolnik
Senior Partner
Napoli Bern Ripka Shkolnik, LLP
(212) 267-3700
Hunter@napolibern.com

This release was issued through WebWire(R). For more information visit http://www.webwire.com.


'/>"/>
SOURCE Napoli Bern Ripka Shkolnik, LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Gene Hunters Fine-Tune Marker for Common Obesity Gene
2. GeneGo Releases Content and Tools From Industry-FDA Driven MetaTox Partnership Via ToxHunter(TM)
3. Health Network Laboratories (HNL) Enters Into License Agreement With Hunter Laboratories to Provide HunterHeart Cardiovascular Disease Management Program.
4. Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco
5. Weikang Bio-Technology to Present at Global Hunter 2010 China Conference on July 13, 2010
6. Lotus Pharmaceuticals to Present at Global Hunter Securities 2010 China Conference
7. Jiangbo Pharmaceuticals to Attend Global Hunter Securities China Conference
8. GeneGos ToxHunter™ Suite of Tools and Content for Systems Toxicology Research Is Now Available
9. Uroplasty to Present at Global Hunter Securities Inaugural Healthcare Conference
10. Nutrastar to Present at the Upcoming 2011 Global Hunter Securities Conference
11. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... -- Report Details What can be expected ... to grow at the fastest rates? This visiongain report ... opportunities and prospects. Our 190-page report provides 124 ... in the industry and the future market prospects. Our ... all the major categories of the ophthalmic devices market. ...
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 ... studies the current and future scenario of the global ... for rising opioid consumption. Severe chronic constipation is a ... resistance to traditional laxatives. Hence, novel targeted therapy has ... of OIC sufferers, launch of targeted medicines, and growing ...
(Date:1/19/2017)... 19, 2017 Accuray Incorporated (Nasdaq: ... Systems continue to set the bar for excellence in ... overall user satisfaction rating among radiation treatment delivery systems ... Buyline Market Intelligence Briefing™. The most recent ratings trend ... among industry peers for 11 of the past 12 ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... ... You”: a fine examination of how God handles sin, including how to let go ... Miller, who, for over ten long years has been waiting to release this powerful insight ... he has been serving the Lord for over twenty years, and he has been preaching ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Land of More and More”: ... of world hunger, and shares the simple and achievable answer. “The Land of More ... of the Fairview Missionary Church in Angola, Indiana where he works with the children’s ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... SF expansion and facility enhancement of their 503A compounding pharmacy located in Ocala, ... growing demand of physicians and patients throughout the United States for high-quality human ...
(Date:1/19/2017)... ... 19, 2017 , ... Remote Medical Technologies (RMT), the leader ... with their iMedHD2™ Portable Teleultrasound System. Compatible with any ultrasound ... HD, dynamic, streaming ultrasound images and video to one or more distant locations ...
(Date:1/19/2017)... Chicago, IL (PRWEB) , ... January 19, 2017 ... ... Bank, N.A., announced it recently provided a new $11,250,000 senior credit facility to ... the new MB credit facility were used to facilitate a recapitalization of MedPro ...
Breaking Medicine News(10 mins):